Serum FGF23 Levels in Normal and Disordered Phosphorus Homeostasis

We investigated if the circulating levels of the phosphaturic factor FGF23 are elevated in subjects with XLH. Although we failed to find a statistically significant increase, FGF23 levels were significantly correlated with the degree of hypophosphatemia in XLH. In contrast, FGF23 levels were markedly increased in subjects with ESRD and correlated inversely with the degree of hyperphosphatemia.

[1]  C. C. Pérez-García,et al.  Renal handling of calcium and phosphorus in experimental renal hyperparathyroidism in dogs. , 2003, Veterinary research.

[2]  Y. Takeuchi,et al.  Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. , 2002, The Journal of clinical endocrinology and metabolism.

[3]  R. Kumar.  New insights into phosphate homeostasis: fibroblast growth factor 23 and frizzled-related protein-4 are phosphaturic factors derived from tumors associated with osteomalacia , 2002, Current opinion in nephrology and hypertension.

[4]  P. Toutouzas,et al.  Basic fibroblast growth factor changes in response to coronary angioplasty in patients with stable angina. , 2002, International journal of cardiology.

[5]  R. Kumar,et al.  Tumors Associated With Oncogenic Osteomalacia Express Genes Important in Bone and Mineral Metabolism , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  H. Sasaki,et al.  Elevated Serum Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Levels in Patients with Thymic Epithelial Neoplasms , 2001, Surgery Today.

[7]  L. Quarles,et al.  Analysis of recombinant Phex: an endopeptidase in search of a substrate. , 2001, American journal of physiology. Endocrinology and metabolism.

[8]  R. Kumar,et al.  FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. , 2001, Biochemical and biophysical research communications.

[9]  G. Strewler.  FGF23, hypophosphatemia, and rickets: Has phosphatonin been found? , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Takeda,et al.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  L. Quarles,et al.  Pathophysiology of X-linked hypophosphatemia, tumor-induced osteomalacia, and autosomal dominant hypophosphatemia: a perPHEXing problem. , 2001, The Journal of clinical endocrinology and metabolism.

[12]  T. Meitinger,et al.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 , 2000, Nature Genetics.

[13]  P. Goodyer,et al.  PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia , 1999, Pediatric Nephrology.

[14]  A. Larsson,et al.  Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients. , 1998, Anticancer research.

[15]  K Nakayama,et al.  Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. , 1997, The Biochemical journal.

[16]  D. Hill,et al.  Increased levels of serum fibroblast growth factor-2 in diabetic pregnant women with retinopathy. , 1997, The Journal of clinical endocrinology and metabolism.

[17]  R. Mazzarella,et al.  Expression and cloning of the human X-linked hypophosphatemia gene cDNA. , 1997, Biochemical and biophysical research communications.

[18]  A. Poustka,et al.  A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets , 1995, Nature Genetics.

[19]  H. Tenenhouse,et al.  The renal phosphate transport defect in normal mice parabiosed to X‐linked hypophosphatemic mice persists after parathyroidectomy , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  N. Weidner,et al.  Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets , 1987, Cancer.

[21]  T. Spector,et al.  The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. , 2001, The Journal of clinical endocrinology and metabolism.

[22]  L. Hefler,et al.  Maternal basic fibroblast growth factor serum levels are associated with pregnancy-induced hypertension. , 2001, Journal of the Society for Gynecologic Investigation.

[23]  R. Kumar.  Phosphatonin--a new phosphaturetic hormone? (lessons from tumour-induced osteomalacia and X-linked hypophosphataemia) , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.